{"entity":{"id":"rejuv-ayac-diagnostic-delay","kind":"technology","name":"How long it takes to diagnose cancer in a young person, and what the evidence actually says","aka":[],"tldr":"Young people often say their cancer took a long time to diagnose, and the research agrees that time to diagnosis varies widely by tumour type and age. What the research does not support is a single number: a systematic review found the studies used different definitions and skewed data that could not be combined, so no meta-analysis was possible.","summary":"This is a subject where the honest answer is a method problem rather than a figure, and saying so is more useful than quoting a median from one hospital series.\n\nThe systematic review. A search from 1948 onward identified 1,665 potentially eligible citations in children and young adults aged 0 to 30, of which 32 papers met the inclusion criteria. Most of the work was European (15 papers) or North American (8). Most focused on brain tumours (10), retinoblastoma (5) and bone and soft tissue sarcomas (4). Twenty-five were hospital-based and only seven were population-based. The summary statistics presented were mostly median time to diagnosis, and the reviewers state that \"the skewed distribution of the data meant comparisons between studies based on medians were difficult and combining studies within a meta-analysis was not appropriate\". Their conclusion is that time to diagnosis \"varies between diagnostic groups and with age at diagnosis in the majority of studies\", and that future research needs \"specific criteria identifying circumstances in which delay has occurred\" alongside \"a defined time line to diagnosis or treatment in every study\".\n\nWhat that means for a reader. There is good reason to think diagnosis in this age group is harder than in children or older adults: the cancers are rare, the symptoms overlap with ordinary adolescent complaints such as back pain, tiredness, headache and weight change, young people present to primary care less often, and the cancers that occur here are not the ones screening programmes or primary care referral rules are built around. There is not good evidence for how long it takes on average or for how much outcome depends on it. The commonly repeated assumption that longer time to diagnosis means more advanced disease and worse survival is, in the reviewers' framing, \"often assumed\" rather than established in this population.\n\nWhy it is graded insufficient. The grade attaches to the proposition that shortening time to diagnosis in this age group improves survival, not to the existence of delay, which is real and reported by young people themselves. The United Kingdom's national evaluation of teenage and young adult services found that young people's own interpretation of the results highlighted \"the importance of the diagnostic experience\", which the professional analysis had not captured, and noted that it \"also incurred costs to TYA/families\".\n\nWhat is being done about it anyway, on other grounds. Awareness campaigns aimed at young people and at general practitioners, symptom checklists built for this age group, and direct-access diagnostic pathways all exist and are reasonable on the grounds of experience and anxiety even without survival evidence. A reader who feels they are not being heard can reasonably ask for a specific test and a specific timeframe, and ask for it to be written down.\n\nWhat comes back, and when: not applicable. What can be recovered here is the record: the project of defining time to diagnosis consistently, so that the question can actually be answered, is still open.","status":"established","asOf":"2026-10-02","wikipedia":"https://en.wikipedia.org/wiki/Childhood_cancer","links":[{"label":"A systematic review of time to diagnosis in children and young adults with cancer (Arch Dis Child 2013)","url":"https://doi.org/10.1136/archdischild-2012-303034"},{"label":"Evaluation of specialist cancer services for teenagers and young adults in England: interpreting BRIGHTLIGHT study results through the lens of young people with cancer (Res Involv Engagem 2025)","url":"https://doi.org/10.1186/s40900-025-00739-7"}],"tags":["rejuvenation","survivorship","paediatric","late-effects","evidence:insufficient"],"related":["teenage-cancer-trust"],"cancers":["ewing-sarcoma","osteosarcoma","hodgkin-lymphoma","paediatric-high-grade-glioma","testicular","childhood-cancers"],"sections":["rejuvenation","supportive-care","early-detection"],"technologies":["rejuv-ayac-distinct-group","rejuv-ayac-services"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":["quality-of-life"],"trials":[],"people":[],"bottlenecks":["b-early-detection","b-rare-cancers"],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"principle":"Time to diagnosis in a rare disease is a skewed distribution with a long tail, so medians from hospital series describe the typical patient poorly and the harmed patient not at all. Without an agreed definition of the interval being measured, from first symptom, first presentation or first referral, and an agreed criterion for what counts as delay, studies cannot be pooled, and the quantity most relevant to outcome cannot be estimated.","strengths":["The variability by tumour type and age is consistently observed","Young people report the diagnostic experience as central, which the service evaluation had missed","The fix is methodological and feasible: define the interval and the delay criterion"],"limitations":["No defensible average time to diagnosis for this age group","No evidence in this population that shortening it improves survival","Most studies are single-hospital rather than population-based"]},"route":"/technologies/rejuv-ayac-diagnostic-delay/","neighbours":{"institution":[{"id":"teenage-cancer-trust","kind":"institution","name":"Teenage Cancer Trust","route":"/institutions/teenage-cancer-trust/"}],"cancer":[{"id":"childhood-cancers","kind":"cancer","name":"Childhood cancers (all types)","route":"/cancers/childhood-cancers/"},{"id":"ewing-sarcoma","kind":"cancer","name":"Ewing sarcoma","route":"/cancers/ewing-sarcoma/"},{"id":"hodgkin-lymphoma","kind":"cancer","name":"Hodgkin lymphoma","route":"/cancers/hodgkin-lymphoma/"},{"id":"osteosarcoma","kind":"cancer","name":"Osteosarcoma","route":"/cancers/osteosarcoma/"},{"id":"paediatric-high-grade-glioma","kind":"cancer","name":"Paediatric high-grade glioma (excluding diffuse midline glioma)","route":"/cancers/paediatric-high-grade-glioma/"},{"id":"testicular","kind":"cancer","name":"Testicular germ cell tumours","route":"/cancers/testicular/"}],"section":[{"id":"early-detection","kind":"section","name":"Early Detection & Screening","route":"/fronts/early-detection/"},{"id":"rejuvenation","kind":"section","name":"Recovery & Rejuvenation","route":"/fronts/rejuvenation/"},{"id":"supportive-care","kind":"section","name":"Supportive Care & Survivorship","route":"/fronts/supportive-care/"}],"technology":[{"id":"rejuv-ayac-distinct-group","kind":"technology","name":"Adolescents and young adults: a group with its own cancers, its own gap and its own needs","route":"/technologies/rejuv-ayac-distinct-group/"},{"id":"rejuv-ayac-services","kind":"technology","name":"Services built for teenagers and young adults, and what the national evaluation found","route":"/technologies/rejuv-ayac-services/"}],"term":[{"id":"quality-of-life","kind":"term","name":"Quality of life","route":"/terms/quality-of-life/"}],"bottleneck":[{"id":"b-rare-cancers","kind":"bottleneck","name":"Rare and paediatric cancers without markets","route":"/bottlenecks/b-rare-cancers/"},{"id":"rejuv-agenda-no-agreed-outcome-measures","kind":"bottleneck","name":"The field cannot pool its own studies, because it has not agreed what to measure","route":"/bottlenecks/rejuv-agenda-no-agreed-outcome-measures/"},{"id":"b-early-detection","kind":"bottleneck","name":"The hardest cancers are found late","route":"/bottlenecks/b-early-detection/"}],"idea":[{"id":"idea-rejuv-core-outcome-set-for-late-effects","kind":"idea","name":"Agree what to measure, so the next systematic review can pool rather than narrate","route":"/ideas/idea-rejuv-core-outcome-set-for-late-effects/"}]}}